May 15, 2017 / 8:33 PM / 2 months ago

BRIEF-Immunocellular Therapeutics Q1 loss per share $1.64

1 Min Read

May 15 (Reuters) - Immunocellular Therapeutics Ltd:

* Immunocellular Therapeutics announces first quarter 2017 financial results

* Q1 loss per share $1.64

* Immunocellular Therapeutics Ltd - Company considering potential strategic alternatives for ICT-107

* Immunocellular Therapeutics Ltd - in light of uncertainties surrounding strategic pursuits, company is deferring a Business Update Conference Call

* Immunocellular Therapeutics - also intends to evaluate strategies to refocus and reallocate resources on stem-To-T-Cell Research Programs Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below